Literature DB >> 14675310

Molecular similarities between primary peritoneal and primary ovarian carcinomas.

L-M Chen1, S D Yamada, Y-S Fu, R L Baldwin, B Y Karlan.   

Abstract

The objective of this paper was to characterize expression patterns of biologic markers to distinguish papillary serous peritoneal carcinoma (PPC) from papillary serous ovarian carcinoma (POC). Immunohistochemical analysis of HER-2/neu, p53, bcl-2, and nm23-H1 expression was performed on archival paraffin-embedded tissues. Antigen expression was compared at ovarian and extra-ovarian sites. Thirty-two PPC cases were compared to 18 POC cases. Mean age, stage, grade, and survival outcome were comparable between the two groups. Antigen expression patterns were not significantly different between PPC and POC for the four markers studied. In all cases, nm23-H1 was expressed. Conversely, bcl-2 was expressed at only a single tissue site in three of 32 (9.4%) PPC cases and in one of 18 (5.6%) POC cases. Eleven of 32 (34.4%) PPC cases overexpressed HER-2/neu, vs. four of 18 (22.2%) POC cases. P53 staining results were positive in 23 of 32 (71.9%) PPC and 13 of 18 (72.2%) POC cases. Intrapatient antigen expression was identical at primary and metastatic tumor sites in 50% of the POC and 48.4% of the PPC cases. We conclude that PPC and POC have a comparable immunohistochemical phenotype for these four molecular markers, which is reflected by their similar clinical courses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675310     DOI: 10.1111/j.1525-1438.2003.13605.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers.

Authors:  Chang K Sung; Dawei Li; Erik Andrews; Ronny Drapkin; Thomas Benjamin
Journal:  Mol Oncol       Date:  2012-12-12       Impact factor: 6.603

2.  Primary peritoneal carcinoma: regional cancer institute experience.

Authors:  Anjum Mariam Ifthikar; Praveen S Rathod; S Shruthi; V R Pallavi; K Shobha; B Shankaranand; K Umadevi; Uttam D Bafna
Journal:  Indian J Surg Oncol       Date:  2014-08-13

3.  Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.

Authors:  Teng Hou; Dongxia Liang; Jiehua He; Xu Chen; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

4.  Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?

Authors:  Marc T Goodman; Yurii B Shvetsov
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

5.  Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.

Authors:  Marc T Goodman; Yurii B Shvetsov
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

6.  Primary Peritoneal Carcinoma Initially Presenting as Atypical Cervical Lymphadenopathy.

Authors:  Yun Mi Kim; Yeong Min Lee; Si Hyeing Lee; Dong Woo Lee; Ki Hyang Kim
Journal:  Case Rep Oncol       Date:  2015-05-28

Review 7.  Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered.

Authors:  Elie Rassy; Tarek Assi; Stergios Boussios; Joseph Kattan; Julie Smith-Gagen; Nicholas Pavlidis
Journal:  Ann Transl Med       Date:  2020-12

8.  Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.

Authors:  Merrina Anugraham; Francis Jacob; Arun V Everest-Dass; Andreas Schoetzau; Sheri Nixdorf; Neville F Hacker; Daniel Fink; Viola Heinzelmann-Schwarz; Nicolle H Packer
Journal:  Mol Oncol       Date:  2017-09-29       Impact factor: 6.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.